Liquid Dosage

Short delivery meets high flexibility

As COVID-19 makes its way around the world, Syntegon Technology has a lot going on behind the scenes to support this ever-changing situation. Along with the research and development efforts for novel vaccines, Syntegon is providing solid solutions regarding fill-finish.

Syntegon developed and offers a highly flexible, medium output …more



Syntegon Delivers Yet Another State-of-the-Art Filling Line for Animal Health Pharmaceuticals

The Minneapolis plant of Syntegon is proud to announce the delivery of its latest animal health pharmaceuticals filling line featuring a closed restricted access barrier system for ultimate operator protection.

Animals play an integral part of our lives, from the food we eat, to our companions.  No matter what role animals play in our lives, their health is important.  Whether protecting the herd from bovine respiratory disease or treating Fido’s kennel cough, the medicines that keep animal populations healthy …more


Updated supply chain for single-use systems

Changes are coming for many peristaltic PreVAS system users.  In order to support you with single-use solutions, Syntegon has extended our cooperation with Sartorius Stedim Biotech.  Moving forward, Sartorius will directly supply current and future peristaltic single-use systems to end users, shortening the supply chain.  This includes direct order placement to Sartorius and direct shipments from Sartorius.  Questions concerning single-use system materials (i.e. certificates, bag, extractables, etc.) …more


Vaccines 101 and Syntegon’s Fill-Finish Portfolio

In the midst of our current, ever-changing worldwide coronavirus crisis, the word on everyone’s mind is vaccine.  Never before have the world’s scientific and pharmaceutical communities felt such a collective rush to bring life-saving vaccines to market. In today’s post, our resident filling systems and single-use technology expert, Dr. Laura Moody, provides an overview of the different types of vaccines, how they work, and how Syntegon’s fill-finish portfolio supports clinical and commercial manufacturing.

 

The intention behind a vaccine is to train the body’s immune cells …more


Syntegon Delivers 16th and 17th Model FLT Small Batch Vial Filler for ATMPs

FLT #16 configured to fill gene therapy products in an isolator

 

The Minneapolis plant of Syntegon is proud to announce the delivery of its 16th and 17th model FLT small batch vial filler for ATMP applications. Configured to fill gene therapy products in an isolator and oncolytic immunotherapies and vaccines in a RABS, respectively, these latest deliveries of the proven FLT platform for RTU vials exemplify the trend towards smaller batches of higher value products and highlight Syntegon’s track record of providing solutions that meet the exacting requirements of the rapidly growing ATMP segment.

The Syntegon FLT vial filler is designed …more


ATMP small batch fillers done right, delivered fast

Get your ATMP filler delivered in 6 months.

The model FLT in a standard RABS configuration from Syntegon is available in six months or less. The Syntegon FLT vial filler is designed as a platform for clinical trial production and small batch manufacturing of high value pharmaceuticals. Combining Syntegon’s know-how and design experience in both vial filler and barrier system technologies, the FLT …more


ADCs & state-of-the-art fill-finish technology (for high potent drugs)

These days people are talking a lot about cell/gene therapy drugs, clinical trials, monoclonal antibodies and other exciting topics around small batch fill-finish solutions. Syntegon provides robust and sustainable solutions at an affordable price for every business size. There are solutions for clinical trials, small batch applications, and higher output rates.

There´s a growing demand for small batch production for ADC products (Antibody Drug Conjugates). The operator safety and the best possible protection for these types of drugs is crucial. Syntegon’s approach is …more




Top of page